With the disruptive technology and the rapid change in the business environment, the current business environment results in a spike in the M&A activity. But is M&A beneficial to companies? Fundamental analysis on the actual financial performance for pre- and post-M&A of the sample M&A case, Bristol Myers Squibb – Celgene Acquisition is conducted to help determine if this business methodology truly bring about benefits to the companies over the study period.
In order to continuously optimize website functionality and user experience, this website uses cookies analysis technology for website operation, analysis, and personalized services.
If you continue to browse this website, it means you agree to the use of cookies on this website.